Pierre-Yves Oehrli, Author at Greater Geneva Bern area - Page 30 of 55

Data protection Impressum

MTTA, a new watchmaking hub, will open in Le Locle by 2028 to foster innovation and collaboration in the industry.

Le Locle will be home to the new MTTA watchmaking center of excellence by 2028

6 May 2024

The Innovation Office of the University of Bern empowers the academic and clinical community to turn groundbreaking ideas into societal and economic value.

Making ideas fly at the University of Bern’s Innovation Office

Top Stories Western Switzerland

Top Stories from Western Switzerland (April 2024)

30 April 2024

NovaMea, a cleantech start-up from the EPFL, has raised USD 3.2 million to advance the research and development of its green hydrogen production technology.

NovaMea secures USD 3.2 million to boost green hydrogen production

30 April 2024

In the canton of Valais, the BlueArk Challenge continues to be a catalyst for innovation in water management, as demonstrated in its latest round where two cutting-edge projects each secured CHF 10,000 in funding.

The BlueArk Challenge rewards two breakthrough technologies for advanced water management

30 April 2024

Takeda Pharmaceutical has announced a CHF 5 million investment in renewable energy for its Neuchâtel facility.

Takeda commits CHF 5 million to renewable energy for its Neuchâtel site

29 April 2024

Risklick, a spin-off from the University of Bern, has unveiled its cutting-edge software, Protocol AI, designed to transform the landscape of pharmaceutical development.

UniBe spin-off Risklick unveils AI tool to streamline clinical trials

29 April 2024

Researchers at the EPFL have engineered lab-grown mini-colons that replicate the development of colorectal tumors with high fidelity.

EPFL scientists create lab-grown mini-colons to advance colorectal cancer research

29 April 2024

The FIF has once again highlighted its commitment to propelling tech innovation in Geneva by awarding significant financial support to three promising projects.

Azure Cell Therapies, FireFly Fusion and Antion Biosciences receive FIF support

29 April 2024

The newly released Swiss Biotech Report 2024 highlights an exceptional year for the Swiss biotech industry, marking a record CHF 7.3 billion in revenues and over CHF 2 billion in capital investments.

The Swiss biotech industry: reliable partners beyond borders

23 April 2024

1 … 26 27 28 29 30 31 32 33 34 … 55